
From Tissue to Mechanism to Decision: Building AI for Computational Oncology
From Data in Biotech by CorrDyn
June 2, 2026 · 47 min · Season 1 · Episode 72
About this episode
The episode discusses the challenges and advancements in biomedical AI, particularly in computational oncology, featuring insights from Arvind Rao.
In this episode of Data in Biotech, host Ross Katz sits down with Arvind Rao, Professor of Computational Medicine and Bioinformatics at the University of Michigan, for a discussion on the gap between what biomedical AI can do and what it can reliably be trusted to do in clinical practice. Arvind's research sits at the intersection of computational oncology and AI governance and his lab works across H&E histopathology, multiplex immunofluorescence, spatial transcriptomics, and single-cell RNA sequencing, not just to build predictive models, but to understand the full lifecycle from data to model to inference, and to ask where that lifecycle can be trusted and where it can't. The conversation moves through two of his recent papers on SPIFEE, a graph-based framework that replaces scalar interaction scores in the tumor microenvironment with spatially resolved functional representations, and a multimodal framework that traces a path from stained tissue slides to nominated drug targets via morphological pattern discovery and spatial transcriptomic mapping. What you’ll learn in this episode: >> Why the field's central failure is not algorithmic but translational and the gap…
People in this episode
Host: Ross Katz
Guest: Arvind Rao
Topics covered
- computational oncology
- biomedical AI
- AI governance
- predictive models
- tumor microenvironment
- spatial transcriptomics
Keywords
- AI
- computational medicine
- histopathology
- drug targets
- morphological pattern discovery
- single-cell RNA sequencing
Mentioned in this episode
Organizations: University of Michigan
More episodes of Data in Biotech
- Cavities in the Data: Building FDA-Cleared AI for Dental Imaging with Overjet · May 13, 2026 · 59 min
- Data as a Moat: Why Biotech's Most Valuable Asset is Buried in a Hard Drive · April 30, 2026 · 43 min
- Markus Gershater on Why Experimental Design in Biotech is Broken and How to Fix It · April 15, 2026 · 41 min
- Data Science and Diagnostic Models - the What, Why and How with Michelle Wiest · April 15, 2026 · 44 min
- The Patient is Not a Document: Foundation Models for Biomedical AI with Standard BioModel · April 15, 2026 · 50 min
- Physics, Free Energy, & Drug Discovery: Inside Schrödinger's Computational Platform · April 1, 2026 · 58 min
Explore listener stats, chart rankings, contacts and more on the Data in Biotech podcast page.